Rhythm Pharmaceuticals (RYTM) Preferred Dividend Payments (2024 - 2026)
Rhythm Pharmaceuticals (RYTM) posted quarterly Preferred Dividend Payments of $1.1 million for Q1 2026, down 16.49% year-over-year from $1.3 million in Q1 2025, and down 17.12% quarter-over-quarter from $1.3 million in Q4 2025.
Rhythm Pharmaceuticals (RYTM) Preferred Dividend Payments (2024 - 2026) Analysis & Trends
Rhythm Pharmaceuticals (RYTM) has reported Preferred Dividend Payments for 3 consecutive years, with $1.1 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Preferred Dividend Payments fell 16.49% year-over-year to $1.1 million; the TTM figure through Mar 2026 stood at $5.2 million (down 2.49% YoY), while the FY2025 annual figure was $5.4 million, up 35.47% from the prior year.
- Preferred Dividend Payments slipped to $1.1 million in Q1 2026 per RYTM's latest filing, from $1.3 million in the prior quarter.
- Across five years, Preferred Dividend Payments topped out at $1.4 million in Q3 2025 and bottomed at $1.1 million in Q1 2026.
- Historically, Preferred Dividend Payments has averaged $1.3 million across 3 years, with a median of $1.3 million in 2024.
- Annual changes were most pronounced in 2025 — Preferred Dividend Payments grew 3.61% — and 2026, when it fell 16.49%.
- Rhythm Pharmaceuticals' Preferred Dividend Payments stood at $1.3 million in 2024, then retreated by 0.52% to $1.3 million in 2025, then fell by 17.12% to $1.1 million in 2026.
- Business Quant data shows RYTM's Preferred Dividend Payments at $1.1 million in Q1 2026, $1.3 million in Q4 2025, and $1.4 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Pref Dividends (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | - |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | Rhythm Pharmaceuticals | 7.95 Bn | 7.62 Bn | 62.32 Mn | 1.07 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.07 Mn |
| Mar 31, 2026 | 1.10 Mn |
| Dec 31, 2025 | 1.33 Mn |
| Sep 30, 2025 | 1.38 Mn |
| Jun 30, 2025 | 1.35 Mn |
| Mar 31, 2025 | 1.32 Mn |
| Dec 31, 2024 | 1.34 Mn |
| Sep 30, 2024 | 1.33 Mn |
| Jun 30, 2024 | 1.30 Mn |